ArticleJournal of inflammation research2022

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.

Erkan Topkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.